Novel TNF receptor-1 inhibitors identified as potential therapeutic candidates for traumatic brain injury
Author
Rowe, Rachel K.Harrison, Jordan L.
Zhang, Hongtao
Bachstetter, Adam D.
Hesson, David P.
O’Hara, Bruce F.
Greene, Mark I.
Lifshitz, Jonathan
Affiliation
Univ Arizona, Coll Med Phoenix, Dept Child HlthUniv Arizona, Coll Med Phoenix, Basic Med Sci
Issue Date
2018-05-22
Metadata
Show full item recordPublisher
BIOMED CENTRAL LTDCitation
Rowe, R. K., Harrison, J. L., Zhang, H., Bachstetter, A. D., Hesson, D. P., O'Hara, B. F., ... Lifshitz, J. (2018). Novel TNF receptor-1 inhibitors identified as potential therapeutic candidates for traumatic brain injury. Journal of Neuroinflammation, 15(1), [154]. DOI: 10.1186/s12974-018-1200-yJournal
JOURNAL OF NEUROINFLAMMATIONRights
© The Author(s). 2018. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License.Collection Information
This item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at repository@u.library.arizona.edu.Abstract
Background: Traumatic brain injury (TBI) begins with the application of mechanical force to the head or brain, which initiates systemic and cellular processes that are hallmarks of the disease. The pathological cascade of secondary injury processes, including inflammation, can exacerbate brain injury-induced morbidities and thus represents a plausible target for pharmaceutical therapies. We have pioneered research on post-traumatic sleep, identifying that injury-induced sleep lasting for 6 h in brain-injured mice coincides with increased cortical levels of inflammatory cytokines, including tumor necrosis factor (TNF). Here, we apply post-traumatic sleep as a physiological bio-indicator of inflammation. We hypothesized the efficacy of novel TNF receptor (TNF-R) inhibitors could be screened using post-traumatic sleep and that these novel compounds would improve functional recovery following diffuse TBI in the mouse. Methods: Three inhibitors of TNF-R activation were synthesized based on the structure of previously reported TNF CIAM inhibitor F002, which lodges into a defined TNFR1 cavity at the TNF-binding interface, and screened for in vitro efficacy of TNF pathway inhibition (I.B phosphorylation). Compounds were screened for in vivo efficacy in modulating post-traumatic sleep. Compounds were then tested for efficacy in improving functional recovery and verification of cellular mechanism. Results: Brain-injured mice treated with Compound 7 (C7) or SGT11 slept significantly less than those treated with vehicle, suggesting a therapeutic potential to target neuroinflammation. SGT11 restored cognitive, sensorimotor, and neurological function. C7 and SGT11 significantly decreased cortical inflammatory cytokines 3 h post-TBI. Conclusions: Using sleep as a bio-indicator of TNF-R-dependent neuroinflammation, we identified C7 and SGT11 as potential therapeutic candidates for TBI.ISSN
1742-2094PubMed ID
29789012Version
Final published versionSponsors
National Institute of Neurological Disorders and Stroke of the National Institutes of Health [R21 NS072611]; PCH Mission Support Funds; Diane and Bruce Halle Foundation; NIH [F31-NS090921]; Science Foundation Arizona Bisgrove Scholarshipae974a485f413a2113503eed53cd6c53
10.1186/s12974-018-1200-y
Scopus Count
Collections
Except where otherwise noted, this item's license is described as © The Author(s). 2018. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License.
Related articles
- Resolvins AT-D1 and E1 differentially impact functional outcome, post-traumatic sleep, and microglial activation following diffuse brain injury in the mouse.
- Authors: Harrison JL, Rowe RK, Ellis TW, Yee NS, O'Hara BF, Adelson PD, Lifshitz J
- Issue date: 2015 Jul
- Omega-3 polyunsaturated fatty acid supplementation attenuates microglial-induced inflammation by inhibiting the HMGB1/TLR4/NF-κB pathway following experimental traumatic brain injury.
- Authors: Chen X, Wu S, Chen C, Xie B, Fang Z, Hu W, Chen J, Fu H, He H
- Issue date: 2017 Jul 24
- Omega-3 polyunsaturated fatty acid attenuates the inflammatory response by modulating microglia polarization through SIRT1-mediated deacetylation of the HMGB1/NF-κB pathway following experimental traumatic brain injury.
- Authors: Chen X, Chen C, Fan S, Wu S, Yang F, Fang Z, Fu H, Li Y
- Issue date: 2018 Apr 20
- Traumatic brain injury-induced neuronal damage in the somatosensory cortex causes formation of rod-shaped microglia that promote astrogliosis and persistent neuroinflammation.
- Authors: Witcher KG, Bray CE, Dziabis JE, McKim DB, Benner BN, Rowe RK, Kokiko-Cochran ON, Popovich PG, Lifshitz J, Eiferman DS, Godbout JP
- Issue date: 2018 Dec
- Glia Maturation Factor (GMF) Regulates Microglial Expression Phenotypes and the Associated Neurological Deficits in a Mouse Model of Traumatic Brain Injury.
- Authors: Ahmed ME, Selvakumar GP, Kempuraj D, Raikwar SP, Thangavel R, Bazley K, Wu K, Khan O, Khan A, Zaheer S, Iyer S, Burton C, James D, Zaheer A
- Issue date: 2020 Nov